Clinical Assessment of Burns in Norway

Overview

Clinical assessment of burn depth and area can be challenging even for experienced surgeons. Still, the assessment is fundamental for the treatment, as it determines the fluid treatment and indication for escharotomy and need for referral to a burn centre.There are few studies comparing the initial evaluation of burn depth and surface with that of a specialist burn centre. The aim of this study was to make such a comparison for a cohort of patients admitted to a specialist burn centre during one year.The cohort was defined as patients transferred to the burn unit at Haukeland university hospital during 2014.

Full Title of Study: “Accordance of Clinical Assessment of Burn Depth and %TBSA Between Referring Hospitals and the National Norwegian Burn Centre”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: June 30, 2021

Interventions

  • Procedure: Clinical assessment
    • Clinical assessment of burn depth and the percentage of total body surface area (TBSA) burnt with any method

Arms, Groups and Cohorts

  • Referring hospital
    • Burn assessments performed in referring hospitals
  • Burn centre
    • Burn assessments performed in the national burn centre

Clinical Trial Outcome Measures

Primary Measures

  • Burn depth
    • Time Frame: 1 year
    • Burn depth measured with any described clinical method.Clinical assessment of depth is a subjective evaluation based on visual and tactile characteristics, that is, wound appearance, capillary refill and wound sensibility to touch and pin prick.
  • The percentage of total body surface area (TBSA) burnt
    • Time Frame: 1 year
    • TBSA measured with any described clinical method, for example, Wallace’s Rule of Nines, Lund and Browder charts, and Palmar Surface Measurement (‘rule of palm’)

Participating in This Clinical Trial

Inclusion Criteria

  • Patients transferred to the burn unit at Haukeland university hospital during 2014 Exclusion Criteria:

  • Readmissions – Patients transported to Haukeland directly from the site of the accident

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Haukeland University Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Ragnvald L Brekke, MD, Principal Investigator, Haukeland University Hospital
  • Overall Contact(s)
    • Ragnvald L Brekke, MD, +4740874208, ragnvald.ljones.brekke@helse-bergen.no

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.